C35H30MoN6O6 (726.60): C, 57.86; H, 4.16; N, 11.57%. Found: C,
57.28; H, 3.96; N, 11.76%. 1H NMR ([D6]acetone): d 5.10 (s, 6 H,
ArCH2O and PhCH2O overlapping), 5.82 [s, 2 H, CH2C(pz)3],
6.45 (m, 3 H, pz-H4), 6.69 (t, 4JH,H = 2.0 Hz, 1 H, p-Ar), 6.78 (d,
4JH,H = 2.0 Hz, 2 H, o-Ar), 7.30–7.45 (m, 10 H, Ph), 8.02 (m, 3 H,
C–O–Cs). MS (ESI+-TOF in THF/MeOH/NH4HCOO 5 mM):
m/z 2001.10 [M + H]+.
General procedure for the preparation of [MoCl2O2{(Gn-dend)-
CH(3,5-Me2pz)2}] (9–12). [MoCl2O2] was weighed into
a
Schlenk tube in a dry-box and THF (15 mL) added. A THF
(15 mL) solution of one equivalent (see below) of the corre-
sponding chelating ligand (Gn-dend)CH(3,5-Me2pz)2 (n = 0–3)
was added, and the resulting yellow solution was stirred for 1 h at
room temperature. The solvent was then removed under vacuum
and the residue either washed with diethyl ether or recrystallized
from a mixture of toluene and hexane to give compounds 9–12 as
white or pale-yellow solids.
1
pz-H5), 8.38 ppm (m, 3 H, pz-H3). 13C{ H} NMR ([D6]acetone): d
70.5 (PhCH2O), 68.6 and 74.2 (-CH2OCH2-), 85.2 [C(pz)3], 102.6
(p-Ar), 107.7 (pz-C4), 108.2 (o-Ar), 128.7 (p-Ph), 128.4 and 129.3
(o- and m-Ph), 133.8 (pz-C5), 138.1 (ipso-Ph), 139.1 (ipso-Ar),
146.3 (pz-C3), 161.1 (m-Ar), 229.9 ppm (CO). IR (KBr pellet):
=
m 1900 and 1774 (vs, CO), 1519 (m, C N), 1598 and 1448 (s,
−1
=
C C), 1297 (s, C–O–Cas), 1160 and 1061 cm (s, C–O–Cs). MS
(ESI+-TOF in THF/MeOH/NH4HCOO 5 mM): m/z 1454.20
[M2]+, 1189.20 [M2 − Mo(CO)6]+, 1116.25 [(2)2Na]+, 727.61 [M +
H]+, 569.23 [2 + Na]+, 411.18 [2 − 2 pz − H]+.
[MoCl2O2{(G0-dend)CH(3,5-Me2pz)2}] (9). (G0-dend)CH(3,5-
Me2pz)2 (79 mg, 0.27 mmol) and [MoCl2O2] (50 mg, 0.25 mmol).
Yield: 110 mg (89%). Anal. Calcd for C18H22Cl2MoN4O2 (493.24):
C, 43.83; H, 4.50; N, 11.36. Found: C, 43.6; H, 4.05; N, 11.55. 1H
NMR (CDCl3): d 2.10 (s, 6H, pz-Me5), 2.74 (s, 6H, pz-Me3), 3.63
[Mo(CO)3{(G2-dend)OCH2C(pz)3}]
(7). (G2-dend)OCH2-
6
C(pz)3 (3; 110 mg, 0.11 mmol) and [Mo(CO)3(g -1,3,5-C6H3Me3)]
(32 mg, 0.11 mmol). Yield: 105 mg (83%). Anal. Calc. for
C63H54MoN6O10 (1151.10): C, 65.74; H, 4.73; N, 7.30%. Found: C,
65.35; H, 4.64; N, 7.19%. 1H NMR ([D6]acetone): d 5.06 (s, 4 H,
(d, JH,H = 7.5 Hz, 2 H, CH2), 5.98 (s, 2 H, pz-H4), 6.09 (t, JH,H
=
7.5 Hz, 1 H, CH), 6.81–6.84 (m, 2 H, Ph), 7.14–7.22 ppm (m,
1
3 H, Ph). 13C{ H} NMR (CDCl3): d 11.6 (pz-Me5), 15.6 (pz-Me3),
G1-ArCH2O), 5.08 (s, 8 H, PhCH2O), 5.10 (s, 2 H, G0-ArCH2O),
43.0 (CH2), 69.8 (CH), 109.7 (pz-C4), 128.9 (p-Ph), 128.8 and
4
5.80 [s, 2 H, CH2C(pz)3], 6.42 (m, 3 H, pz-H4), 6.64 (t, JH,H
=
129.1 (o- and m-Ph), 134.4 (ipso-Ph), 144.2 (pz-C5), 157.8 ppm
4
3
=
=
2.1 Hz, 2 H, G1-p-Ar), 6.68 (t, JH,H = 2.1 Hz, 1 H, G0-p-Ar),
(pz-C ). IR (KBr pellet): m 1562 (s, C N), 1620 (w, C C), 1459
4
4
−1
+
=
=
=
6.72 (d, JH,H = 2.1 Hz, 4 H, G1-o-Ar), 6.81 (d, JH,H = 2.1 Hz,
(s, C C), 950 (s, Mo Oas), 914 cm (s, Mo Os). MS (ESI -
TOF in THF/MeOH/NH4HCOO 5 mM): m/z 611.79 [(L)2Na]+,
317.39 [L + Na]+, 294.40 [L]+, 199.28 [L − Me2pz]+; L = (G0-
dend)CH(3,5-Me2pz)2.
2 H, G0-o-Ar), 7.26–7.45 (m, 20 H, Ph), 7.98 (m, 3 H, pz-H5),
8.36 ppm (m, 3 H, pz-H3). 13C{ H} NMR ([D6]acetone): d 70.3
1
(G1-ArCH2O), 70.5 (PhCH2O), 68.5 and 74.4 (–CH2OCH2–),
85.1 [C(pz)3], 101.9 (G1-p-Ar), 102.7 (G0-p-Ar), 107.2 (G1-o-Ar),
107.6 (pz-C4), 108.6 (G0-o-Ar), 128.6 (p-Ph), 128.5 and 129.3 (o-
and m-Ph), 133.8 (pz-C5), 138.1 (ipso-Ph), 139.0 (G0-ipso-Ar),
140.5 (G1-ipso-Ar), 146.1 (pz-C3), 161.0 (G1-m-Ar), 161.1
(G0-m-Ar), 229.9 ppm (CO). IR (KBr pellet): m 1904 and 1785
[MoCl2O2{(G1-dend)CH(3,5-Me2pz)2}] (10). (G1-dend)CH-
(3,5-Me2pz)2 (127 mg, 0.25 mmol) and [MoCl2O2] (48 mg,
0.24 mmol). Yield: 146 mg (86%). Anal. Calc. for C32H34Cl2-
MoN4O4 (705.49): C, 54.48; H, 4.86; N, 7.94%. Found: C, 54.44;
H, 4.71; N, 8.32%. 1H NMR (CDCl3): d 2.05 (s, 6 H, pz-Me5), 2.73
(s, 6 H, pz-Me3), 3.53 (d, JH,H = 7.5 Hz, 2 H, CH2), 4.90 (s, 4 H,
PhCH2O), 5.97 (s, 2 H, pz-H4), 6.00 (t, JH,H = 7.5 Hz, 1 H, CH
partially overlapped), 6.04 (d, 4JH,H = 2.2 Hz, 2 H, o-Ar), 6.46 (t,
=
=
(vs, CO), 1517 (m, C N), 1594 and 1451 (vs, C C), 1295 (s,
C–O–Cas), 1155 and 1053 cm−1 (s, C–O–Cs). MS (ESI+-TOF in
THF/MeOH/NH4HCOO 5 mM): m/z 1152.10 [M + H]+, 994.11
[3 + Na]+, 768.91 [3–3 pz − H]+.
1
4JH,H = 2.2 Hz, 1 H, p-Ar), 7.30–7.40 ppm (m, 10 H, Ph). 13C{ H}
NMR (CDCl3): d 11.6 (pz-Me5), 16.6 (pz-Me3), 43.0 (CH2), 69.6
(CH), 69.9 (PhCH2O), 101.7 (p-Ar), 107.9 (pz-C4), 108.0 (o-Ar),
127.4 and 128.7 (o- and m-Ph), 128.1 (p-Ph), 136.5 (ipso-Ar), 136.6
(ipso-Ph), 144.3 (pz-C5), 157.7 (pz-C3), 159.9 ppm (m-Ar). IR (KBr
[Mo(CO)3{(G3-dend)OCH2C(pz)3}]
(8). (G2-dend)OCH2-
6
C(pz)3 (4; 114 mg, 0.06 mmol) and [Mo(CO)3(g -1,3,5-C6H3Me3)]
(18 mg, 0.06 mmol). Yield: 102 mg (85%). Anal. Calc. for
C119H102MoN6O18 (2000.09): C, 71.46; H, 5.14; N, 4.20%. Found:
C, 71.21; H, 4.93; N, 3.85%. 1H NMR ([D6]acetone): d 5.00 (s, 8 H,
G2-ArCH2O), 5.02 (s, 4 H, G1-ArCH2O), 5.06 (s, 18 H, PhCH2O
and G0-ArCH2O overlapping), 5.77 [s, 2 H, CH2C(pz)3], 6.40
(m, 3 H, pz-H4), 6.61 (m, 7 H, G0-p-Ar, G1-p-Ar and G2-p-Ar
=
=
pellet): m 1561 (s, C N), 1595 and 1460 (s, C C), 1295 (vs, C–
−1
=
O–Cas), 1151 and 1030 (s, C–O–Cs), 956 (s, Mo Oas), 920 cm
+
=
(s, Mo Os). MS (ESI -TOF in THF/MeOH/NH4HCOO 5 mM):
m/z = 1036.29 [(L)2Na]+, 529.64 [L + Na]+, 507.66 [L + H]+, 411.52
[L − Me2pz]+, 316.40 [L − 2 Me2pz]+; L = (G1-dend)CH(3,5-
Me2pz)2.
4
overlapping), 6.68 (d, JH,H = 2.2 Hz, 4 H, G1-o-Ar), 6.71 (d,
4JH,H = 2.2 Hz, 8 H, G2-o-Ar), 6.78 (d, 4JH,H = 2.2 Hz, 2 H, G0-o-
Ar), 7.26–7.45 (m, 40 H, Ph), 7.97 (m, 3 H, pz-H5), 8.32 ppm (m,
[MoCl2O2{(G2-dend)CH(3,5-Me2pz)2}] (11). (G2-dend)CH-
(3,5-Me2pz)2 (140 mg, 0.15 mmol) and [MoCl2O2] (30 mg,
0.15 mmol). Yield: 140 mg (87%). Anal. Calc. for
C60H58Cl2MoN4O8 (1129.99): C, 63.78; H, 5.17; N, 4.96%. Found:
1
3 H, pz-H3). 13C{ H} NMR ([D6]acetone): d 70.4 (G1-ArCH2O),
70.5 (G2-ArCH2O and PhCH2O overlapping), 68.6 and 74.4
(-CH2OCH2-), 85.1 [C(pz)3], 102.0 (G2-p-Ar and G1-p-Ar
overlapping), 102.8 (G0-p-Ar), 107.3 (G2-o-Ar), 107.4 (G1-o-Ar),
107.7 (pz-C4), 108.6 (G0-o-Ar), 128.6 (p-Ph), 128.5 and 129.3 (o-
and m-Ph), 133.7 (pz-C5), 138.1 (ipso-Ph), 139.0 (G0-ipso-Ar),
140.5 (G1-ipso-Ar), 140.6 (G2-ipso-Ar), 146.3 (pz-C3), 161.0
(G1-m-Ar), 161.1 (G2-m-Ar), 161.2 (G0-m-Ar), 230.0 ppm (CO).
1
C, 63.81; H, 5.46; N, 5.01%. H NMR (CDCl3): d 2.01 (s, 6 H,
pz-Me5), 2.71 (s, 6 H, pz-Me3), 3.52 (d, JH,H = 7.3 Hz, 2 H, CH2),
4.84 (s, 4 H, ArCH2O), 5.01 (s, 8 H, PhCH2O), 5.95 (s, 2 H, pz-
H4), 5.98 (t, JH,H = 7.3 Hz, 1 H, CH partially overlapped), 6.01
4
4
(d, JH,H = 2.2 Hz, 2 H, G0-o-Ar), 6.48 (t, JH,H = 2.2 Hz, 1 H,
IR (KBr pellet): m 1905 and 1787 (vs, CO), 1518 (w, C N), 1595
G0-p-Ar), 6.55 (t, 4JH,H = 2.2 Hz, 2 H, G1-p-Ar), 6.66 (d, 4JH,H
=
=
−1
1
=
and 1449 (vs, C C), 1294 (s, C–O–Cas), 1152 and 1051 cm (vs,
2.2 Hz, 4 H, G1-o-Ar), 7.30–7.44 ppm (m, 20 H, Ph). H NMR
This journal is
The Royal Society of Chemistry 2007
Dalton Trans., 2007, 5658–5669 | 5665
©